Intrahepatic cholangiocarcinoma exhibits immunogenic features through the expression of immune checkpoint molecules, programmed cell death ligand 1 (PDL-1) and cytokine T-lymphocyte-associated protein-4 (CTLA-4) in the tumor microenvironment [14,15]. The gene discussed is CD274; the disease is intrahepatic cholangiocarcinoma.